Huong D. Meeks

Huong D. Meeks, MPH, MStat, PhD

Languages spoken: English, Vietnamese

Academic Information

Departments Primary - Pediatrics

Divisions:

Academic Office Information

huong.meeks@hsc.utah.edu

Dr. Huong Meeks completed her Ph.D. in Nutritional Epidemiology at Utah State University and her post-doctoral fellowship in Genetic Epidemiology at Huntsman Cancer Institute. She then worked as a biostatistician at the Pedigree and Population Resources Department at HCI where she collaborated with researchers across multiple disciplines including obstetrics/gynecology, oncology, urology, nutrition, neuropsychology, among others. She joined the faculty of the University of Utah School of Medicine as Assistant Professor of Pediatric Critical Care in 2022. Dr. Meeks is a life course epidemiologist and demographer with special expertise in population health and longitudinal data, familial and survival analysis.

Her research interest focuses on the longitudinal effects of family, individual and neighborhood socio-economic status, and other social determinants of health on adverse health outcomes.

Education History

Postdoctoral Fellowship Huntsman Cancer Institute
 Postdoctoral Research Fellow
Utah State University
 MStat
Graduate Training Utah State University
 PhD
Utah State University
 MS
Undergraduate Brigham Young University–Idaho
 BS

Selected Publications

Journal Article

  1. Gill AS, Meeks H, Curtin K, Alt JA (2022). Tobacco Use Increases the Adjusted Risk of Revision Endoscopic Sinus Surgery in Patients With Chronic Rhinosinusitis. Am J Rhinol Allergy, 19458924221105926.
  2. Barnard ME, Meeks H, Jarboe EA, Albro J, Camp NJ, Doherty JA (2022). Familial risk of epithelial ovarian cancer after accounting for gynaecological surgery: a population-based study. J Med Genet.
  3. Tay DL, Ornstein KA, Meeks H, Utz RL, Smith KR, Stephens C, Hashibe M, Ellington L (2021). Evaluation of Family Characteristics and Multiple Hospitalizations at the End of Life: Evidence from the Utah Population Database. J Palliat Med, 25(3), 376-387.
  4. Smith KA, Gill AS, Beswick DM, Meeks H, Oakley GM, Yim M, Curtin K, Orlandi RR, Alt JA (2021). Cystic Fibrosis Increases Long-Term Revision Rates of Endoscopic Sinus Surgery in Patients With Comorbid Chronic Rhinosinusitis. Am J Rhinol Allergy, 36(2), 222-228.
  5. Patel DP, Meeks HT, Pastuszak AW, Hanson HA, Smith KR, Letourneau JM, Hotaling JM (2021). Lower female partner live birth rate in male cancer survivors: An age-matched cohort analysis of the Utah Population Database. Andrologia, 54(1), e14293.
  6. Garg D, Meeks HD, Johnstone E, Berga SL, Smith KR, Hotaling J, Letourneau JM (2021). Cancer treatment is associated with a measurable decrease in live births in a large, population-based study. F S Rep, 2(4), 462-467.
  7. Gill AS, Smith KA, Meeks H, Oakley GM, Curtin K, LeClair L, Howe H, Orlandi RR, Alt JA (2021). Asthma increases long-term revision rates of endoscopic sinus surgery in chronic rhinosinusitis with and without nasal polyposis. Int Forum Allergy Rhinol, 11(8), 1197-1206.
  8. Schacht R, Meeks H, Fraser A, Smith KR (2021). Was Cinderella just a fairy tale? Survival differences between stepchildren and their half-siblings. Philos Trans R Soc Lond B Biol Sci, 376(1827), 20200032.
  9. Patel DP, Meeks HT, Hanson HA, Pastuszak AW, Hotaling JM, Smith KR (2021). Lower total motile count is associated with smaller historic intergenerational family size: a pedigree analysis from the Utah Population Database. J Assist Reprod Genet, 38(5), 1207-1213.
  10. Dude AM, Smid MC, Branch DW, West J, Meeks H, Yu Z, Fraser A, Smith K, Reddy D (2021). Interpregnancy Body Mass Index Change and Offspring Mortality Risk following the Second Pregnancy. Am J Perinatol.
  11. Kazmers NH, Meeks HD, Novak KA, Yu Z, Fulde GL, Thomas JL, Barker T, Jurynec MJ (2021). Familial Clustering of Erosive Hand Osteoarthritis in a Large Statewide Cohort. Arthritis Rheumatol, 73(3), 440-447.
  12. Schacht R, Macfarlan SJ, Meeks H, Cervantes PL, Morales F (2020). Male survival advantage on the Baja California peninsula. Biol Lett, 16(11), 20200600.
  13. DeKeyser GJ, Anderson MB, Meeks HD, Pelt CE, Peters CL, Gililland JM (2020). Socioeconomic Status May Not Be a Risk Factor for Periprosthetic Joint Infection. J Arthroplasty, 35(7), 1900-1905.
  14. Cawthon RM, Meeks HD, Sasani TA, Smith KR, Kerber RA, OBrien E, Baird L, Dixon MM, Peiffer AP, Leppert MF, Quinlan AR, Jorde LB (2020). Germline mutation rates in young adults predict longevity and reproductive lifespan. Sci Rep, 10(1), 10001.
  15. Hammad IA, Meeks H, Fraser A, Theilen LH, Esplin MS, Smith KR, Varner MW (2019). Risks of cause-specific mortality in offspring of pregnancies complicated by hypertensive disease of pregnancy. Am J Obstet Gynecol, 222(1), 75.e1-75.e9.
  16. Duensing I, Anderson MB, Meeks HD, Curtin K, Gililland JM (2019). Patients with Type-1 Diabetes Are at Greater Risk of Periprosthetic Joint Infection: A Population-Based, Retrospective, Cohort Study. J Bone Joint Surg Am, 101(20), 1860-1867.
  17. Hanson GR, McMillan S, Mower K, Bruett CT, Duarte L, Koduri S, Pinzon L, Warthen M, Smith K, Meeks H, Trump B (2019). Comprehensive oral care improves treatment outcomes in male and female patients with high-severity and chronic substance use disorders. J Am Dent Assoc, 150(7), 591-601.
  18. Smith KA, Orlandi RR, Oakley G, Meeks H, Curtin K, Alt JA (2018). Long-term revision rates for endoscopic sinus surgery. Int Forum Allergy Rhinol, 9(4), 402-408.
  19. Chernenko A, Meeks H, Smith KR (2019). Examining validity of body mass index calculated using height and weight data from the US driver license. BMC Public Health, 19(1), 100.
  20. Patel B, Meeks H, Wan Y, Johnstone EB, Glenn M, Smith KR, Hotaling JM (2018). Transgenerational effects of chemotherapy: Both male and female children born to women exposed to chemotherapy have fewer children. Cancer Epidemiol, 56, 1-5.
  21. Theilen LH, Meeks H, Fraser A, Esplin MS, Smith KR, Varner MW (2018). Long-term mortality risk and life expectancy following recurrent hypertensive disease of pregnancy. Am J Obstet Gynecol, 219(1), 107.e1-107.e6.
  22. Colombo M, Lpez-Perolio I, Meeks HD, Caleca L, Parsons MT, Li H, De Vecchi G, Tudini E, Foglia C, Mondini P, Manoukian S, Behar R, Garcia EBG, Meindl A, Montagna M, Niederacher D, Schmidt AY, Varesco L, Wappenschmidt B, Bolla MK, Dennis J, Michailidou K, Wang Q, Aittomki K, Andrulis IL, Anton-Culver H, Arndt V, Beckmann MW, Beeghly-Fadel A, Benitez J, Boeckx B, Bogdanova NV, Bojesen SE, Bonanni B, Brauch H, Brenner H, Burwinkel B, Chang-Claude J, Conroy DM, Couch FJ, Cox A, Cross SS, Czene K, Devilee P, Drk T, Eriksson M, Fasching PA, Figueroa J, Fletcher O, Flyger H, Gabrielson M, Garca-Closas M, Giles GG, Gonzlez-Neira A, Gunel P, Haiman CA, Hall P, Hamann U, Hartman M, Hauke J, Hollestelle A, Hopper JL, Jakubowska A, Jung A, Kosma VM, Lambrechts D, Le Marchand L, Lindblom A, Lubinski J, Mannermaa A, Margolin S, Miao H, Milne RL, Neuhausen SL, Nevanlinna H, Olson JE, Peterlongo P, Peto J, Pylks K, Sawyer EJ, Schmidt MK, Schmutzler RK, Schneeweiss A, Schoemaker MJ, See MH, Southey MC, Swerdlow A, Teo SH, Toland AE, Tomlinson I, Truong T, van Asperen CJ, van den Ouweland AMW, van der Kolk LE, Winqvist R, Yannoukakos D, Zheng W, kConFabAOCS Investigators, Dunning AM, Easton DF, Henderson A, Hogervorst FBL, Izatt L, Offitt K, Side LE, van Rensburg EJ, Embrace S, Hebon S, McGuffog L, Antoniou AC, Chenevix-Trench G, Spurdle AB, Goldgar DE, Hoya M, Radice P (2018). The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. Hum Mutat, 39(5), 729-741.
  23. Moghadasi S, Meeks HD, Vreeswijk MP, Janssen LA, Borg, Ehrencrona H, Paulsson-Karlsson Y, Wappenschmidt B, Engel C, Gehrig A, Arnold N, Hansen TVO, Thomassen M, Jensen UB, Kruse TA, Ejlertsen B, Gerdes AM, Pedersen IS, Caputo SM, Couch F, Hallberg EJ, van den Ouweland AM, Colle MJ, Teugels E, Adank MA, van der Luijt RB, Mensenkamp AR, Oosterwijk JC, Blok MJ, Janin N, Claes KB, Tucker K, Viassolo V, Toland AE, Eccles DE, Devilee P, Van Asperen CJ, Spurdle AB, Goldgar DE, Garca EG (2017). The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium. J Med Genet, 55(1), 15-20.
  24. Shimelis H, Mesman RLS, Von Nicolai C, Ehlen A, Guidugli L, Martin C, Callja FMGR, Meeks H, Hallberg E, Hinton J, Lilyquist J, Hu C, Aalfs CM, Aittomki K, Andrulis I, Anton-Culver H, Arndt V, Beckmann MW, Benitez J, Bogdanova NV, Bojesen SE, Bolla MK, Borresen-Dale AL, Brauch H, Brennan P, Brenner H, Broeks A, Brouwers B, Brning T, Burwinkel B, Chang-Claude J, Chenevix-Trench G, Cheng CY, Choi JY, Colle JM, Cox A, Cross SS, Czene K, Darabi H, Dennis J, Drk T, Dos-Santos-Silva I, Dunning AM, Fasching PA, Figueroa J, Flyger H, Garca-Closas M, Giles GG, Glendon G, Gunel P, Haiman CA, Hall P, Hamann U, Hartman M, Hogervorst FB, Hollestelle A, Hopper JL, Ito H, Jakubowska A, Kang D, Kosma VM, Kristensen V, Lai KN, Lambrechts D, Marchand LL, Li J, Lindblom A, Lophatananon A, Lubinski J, Machackova E, Mannermaa A, Margolin S, Marme F, Matsuo K, Miao H, Michailidou K, Milne RL, Muir K, Neuhausen SL, Nevanlinna H, Olson JE, Olswold C, Oosterwijk JJC, Osorio A, Peterlongo P, Peto J, Pharoah PDP, Pylks K, Radice P, Rashid MU, Rhenius V, Rudolph A, Sangrajrang S, Sawyer EJ, Schmidt MK, Schoemaker MJ, Seynaeve C, Shah M, Shen CY, Shrubsole M, Shu XO, Slager S, Southey MC, Stram DO, Swerdlow A, Teo SH, Tomlinson I, Torres D, Truong T, van Asperen CJ, van der Kolk LE, Wang Q, Winqvist R, Wu AH, Yu JC, Zheng W, Zheng Y, Leary J, Walker L, Foretova L, Fostira F, Claes KBM, Varesco L, Moghadasi S, Easton DF, Spurdle A, Devilee P, Vrieling H, Monteiro ANA, Goldgar DE, Carreira A, Vreeswijk MPG, Couch FJ, for kConFabAOCS Investigators, for NBCS Collaborators (2017). BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer. Cancer Res, 77(11), 2789-2799.
  25. de la Hoya M, Soukarieh O, Lpez-Perolio I, Vega A, Walker LC, van Ierland Y, Baralle D, Santamaria M, Lattimore V, Wijnen J, Whiley P, Blanco A, Raponi M, Hauke J, Wappenschmidt B, Becker A, Hansen TV, Behar R, Investigators K, Niederacher D, Arnold N, Dworniczak B, Steinemann D, Faust U, Rubinstein W, Hulick PJ, Houdayer C, Caputo SM, Castera L, Pesaran T, Chao E, Brewer C, Southey MC, van Asperen CJ, Singer CF, Sullivan J, Poplawski N, Mai P, Peto J, Johnson N, Burwinkel B, Surowy H, Bojesen SE, Flyger H, Lindblom A, Margolin S, Chang-Claude J, Rudolph A, Radice P, Galastri L, Olson JE, Hallberg E, Giles GG, Milne RL, Andrulis IL, Glendon G, Hall P, Czene K, Blows F, Shah M, Wang Q, Dennis J, Michailidou K, McGuffog L, Bolla MK, Antoniou AC, Easton DF, Couch FJ, Tavtigian S, Vreeswijk MP, Parsons M, Meeks HD, Martins A, Goldgar DE, Spurdle AB (2016). Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms. Hum Mol Genet, 25(11), 2256-2268.
  26. Li J, Meeks H, Feng BJ, Healey S, Thorne H, Makunin I, Ellis J, kConFab Investigators, Campbell I, Southey M, Mitchell G, Clouston D, Kirk J, Goldgar D, Chenevix-Trench G (2015). Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families. J Med Genet, 53(1), 34-42.
  27. Meeks HD, Song H, Michailidou K, Bolla MK, Dennis J, Wang Q, Barrowdale D, Frost D, EMBRACE, McGuffog L, Ellis S, Feng B, Buys SS, Hopper JL, Southey MC, Tesoriero A, kConFab Investigators, James PA, Bruinsma F, Campbell IG, Australia Ovarian Cancer Study Group, Broeks A, Schmidt MK, Hogervorst FB, HEBON, Beckman MW, Fasching PA, Fletcher O, Johnson N, Sawyer EJ, Riboli E, Banerjee S, Menon U, Tomlinson I, Burwinkel B, Hamann U, Marme F, Rudolph A, Janavicius R, Tihomirova L, Tung N, Garber J, Cramer D, Terry KL, Poole EM, Tworoger SS, Dorfling CM, van Rensburg EJ, Godwin AK, Gunel P, Truong T, GEMO Study Collaborators, Stoppa-Lyonnet D, Damiola F, Mazoyer S, Sinilnikova OM, Isaacs C, Maugard C, Bojesen SE, Flyger H, Gerdes AM, Hansen TV, Jensen A, Kjaer SK, Hogdall C, Hogdall E, Pedersen IS, Thomassen M, Benitez J, Gonzlez-Neira A, Osorio A, Hoya Mde L, Segura PP, Diez O, Lazaro C, Brunet J, Anton-Culver H, Eunjung L, John EM, Neuhausen SL, Ding YC, Castillo D, Weitzel JN, Ganz PA, Nussbaum RL, Chan SB, Karlan BY, Lester J, Wu A, Gayther S, Ramus SJ, Sieh W, Whittermore AS, Monteiro AN, Phelan CM, Terry MB, Piedmonte M, Offit K, Robson M, Levine D, Moysich KB, Cannioto R, Olson SH, Daly MB, Nathanson KL, Domchek SM, Lu KH, Liang D, Hildebrant MA, Ness R, Modugno F, Pearce L, Goodman MT, Thompson PJ, Brenner H, Butterbach K, Meindl A, Hahnen E, Wappenschmidt B, Brauch H, Brning T, Blomqvist C, Khan S, Nevanlinna H, Pelttari LM, Aittomki K, Butzow R, Bogdanova NV, Drk T, Lindblom A, Margolin S, Rantala J, Kosma VM, Mannermaa A, Lambrechts D, Neven P, Claes KB, Maerken TV, Chang-Claude J, Flesch-Janys D, Heitz F, Varon-Mateeva R, Peterlongo P, Radice P, Viel A, Barile M, Peissel B, Manoukian S, Montagna M, Oliani C, Peixoto A, Teixeira MR, Collavoli A, Hallberg E, Olson JE, Goode EL, Hart SN, Shimelis H, Cunningham JM, Giles GG, Milne RL, Healey S, Tucker K, Haiman CA, Henderson BE, Goldberg MS, Tischkowitz M, Simard J, Soucy P, Eccles DM, Le N, Borresen-Dale AL, Kristensen V, Salvesen HB, Bjorge L, Bandera EV, Risch H, Zheng W, Beeghly-Fadiel A, Cai H, Pylks K, Tollenaar RA, Ouweland AM, Andrulis IL, Knight JA, OCGN, Narod S, Devilee P, Winqvist R, Figueroa J, Greene MH, Mai PL, Loud JT, Garca-Closas M, Schoemaker MJ, Czene K, Darabi H, McNeish I, Siddiquil N, Glasspool R, Kwong A, Park SK, Teo SH, Yoon SY, Matsuo K, Hosono S, Woo YL, Gao YT, Foretova L, Singer CF, Rappaport-Feurhauser C, Friedman E, Laitman Y, Rennert G, Imyanitov EN, Hulick PJ, Olopade OI, Senter L, Olah E, Doherty JA, Schildkraut J, Koppert LB, Kiemeney LA, Massuger LF, Cook LS, Pejovic T, Li J, Borg A, fverholm A, Rossing MA, Wentzensen N, Henriksson K, Cox A, Cross SS, Pasini BJ, Shah M, Kabisch M, Torres D, Jakubowska A, Lubinski J, Gronwald J, Agnarsson BA, Kupryjanczyk J, Moes-Sosnowska J, Fostira F, Konstantopoulou I, Slager S, Jones M, PRostate cancer AssoCiation group To Investigate Cancer Associated aLterations in the genome, Antoniou AC, Berchuck A, Swerdlow A, Chenevix-Trench G, Dunning AM, Pharoah PD, Hall P, Easton DF, Couch FJ, Spurdle AB, Goldgar DE (2015). BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. J Natl Cancer Inst, 108(2).